Tacrolimus pharmacogenetics: bringing the laboratory into the clinic.
McLaren
Andrew
A
University of Oxford, Nuffield Department of Surgery, John Radcliffe Hospital, Oxford, UK.
D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008099:Liver / Q000201:enzymology; D011110:Polymorphism, Genetic; D015203:Reproducibility of Results; D016559:Tacrolimus / Q000493:pharmacokinetics* / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D003577:Cytochrome P-450 Enzyme System; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A; D016559:Tacrolimus